Clovis Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Clovis Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2014 to Q3 2022.
  • Clovis Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $4.89M, a 30.2% decline year-over-year.
  • Clovis Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $24M, a 21.2% decline year-over-year.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25.5M, a 49.9% decline from 2020.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $50.8M, a 6.46% decline from 2019.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $54.3M, a 10.6% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $24M $4.89M -$2.11M -30.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $26.1M $5.4M -$1.96M -26.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $28M $6.63M +$2.59M +64.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $25.5M $7.05M -$4.98M -41.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 $30.4M $7M -$5.49M -44% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $35.9M $7.36M -$5.95M -44.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $41.9M $4.04M -$8.92M -68.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $50.8M $12M -$526K -4.19% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $51.3M $12.5M -$1.49M -10.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $52.8M $13.3M -$817K -5.78% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $53.6M $13M -$679K -4.98% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $54.3M $12.6M +$16M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $38.3M $14M +$3.03M +27.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $35.2M $14.1M -$725K -4.88% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $36M $13.6M -$13.1M -49% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $49.1M -$3.48M -$16M -128% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $65.1M $10.9M -$1.69M -13.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $66.8M $14.9M +$4.24M +39.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $62.5M $26.8M +$17.8M +199% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-02
Q4 2017 $44.7M $12.5M +$2.46M +24.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $42.3M $12.6M +$3.43M +37.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $38.8M $10.6M +$1.04M +10.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $37.8M $8.95M -$2.02M -18.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $39.8M $10.1M -$848K -7.78% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $40.6M $9.2M -$3.2M -25.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $43.8M $9.58M +$1.21M +14.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $42.6M $11M +$2.28M +26.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $40.4M $10.9M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $12.4M +$6.97M +128% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $8.37M +$3.16M +60.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $8.68M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 $5.44M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $5.21M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.